Prostacyclin and prostaglandin E2 mediate reduction of increased mean arterial pressure during cardiopulmonary bypass by aspiration of shed pulmonary venous blood-Reference-Cited by-同舟云学术

Prostacyclin and prostaglandin E2 mediate reduction of increased mean arterial pressure during cardiopulmonary bypass by aspiration of shed pulmonary venous blood

Published:1990-10 Issue:4 Volume:100 Page:546-551
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Lavee Jacob,Naveh Nava,Dinbar Inge,Shinfeld Ami,Goor Daniel A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference16 articles.

1. Some direct and reflex cardiovascular actions of prostacyclin (PGI2) and prostaglandin E2 in anaesthetized dogs;Chapple;Br J Pharmacol,1980

2. Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1 with those of prostaglandin E2 in rats and rabbits;Armstrong;Br J Pharmacol,1978

3. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation;Gryglewski;Nature,1978

4. Prostacyclin is a circulating hormone;Moncada;Nature,1978

5. Production of 6-oxo-PGF1 by human lung in vivo;Hensby;Lancet,1979

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology of Cardiopulmonary Bypass;Principles of Miniaturized ExtraCorporeal Circulation;2012-10-16

2. Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery;The Journal of Thoracic and Cardiovascular Surgery;2009-03

3. Minimally Invasive Closed Circuit Versus Standard Extracorporeal Circulation for Aortic Valve Replacement;The Annals of Thoracic Surgery;2007-02

4. Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating;The Journal of Thoracic and Cardiovascular Surgery;2003-11

5. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass;The Journal of Thoracic and Cardiovascular Surgery;2002-05